iShares U.S. Healthcare ETF (IYH) Technical Analysis
$71.16▲0.38%
Market is closed - opens 7 PM, 13 Aug 2026
Insights
- iShares U.S. Healthcare ETF is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for iShares U.S. Healthcare ETF stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, iShares U.S. Healthcare ETF stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for iShares U.S. Healthcare ETF stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 65.69 | Sell |
Stochastic | 84.88, 89.23 | Sell |
Ultimate Oscillator | 59.22 | Neutral |
Stochastic Relative Strength Index | 85.0, 69.11 | Neutral |
Moving Average Convergence Divergence | 0.97, 0.85 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 69.39 | Buy |
20 | 68.68 | Buy |
50 | 66.77 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 69.62 | Buy |
20 | 68.88 | Buy |
50 | 67.09 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 68.97 | Neutral |
20 | 68.59 | Neutral |
50 | 66.5 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 70.43 | Buy |
20 | 70.16 | Buy |
50 | 69.49 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 70.72 | Buy |
20 | 70.23 | Sell |
50 | 70.45 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 72.82 |
Resistance L2 | 71.99 |
Resistance L1 | 71.56 |
Pivot Point | 70.73 |
Support L1 | 70.3 |
Support L2 | 69.47 |
Support L3 | 69.04 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.